Feds, Insurers Will Pick Up Tab for First Round of Vaccines
With Pfizer Inc. and BioNTech’s coronavirus vaccine on the cusp of FDA authorization, Moderna Inc.’s offering not far behind and AstraZeneca plc also touting promising results from its vaccine, in the coming months there will undoubtedly be a variety of vaccines being administered to Americans. While in normal circumstances private insurers might steer members toward one manufacturer’s vaccine over another, or even refuse to cover certain inoculations, policy experts say that the usual rules do not apply when it comes to the COVID-19 pandemic.
“Few things in health policy are simple, but in the case of the COVID-19 vaccine, there is a very simple take-home message, which is that no one going to get the vaccine will be charged for the vaccine or its administration, no matter what type of insurance they have, or whether they have insurance at all,” Karyn Schwartz, a senior fellow at the Kaiser Family Foundation (KFF), said during a Dec. 3 web briefing about vaccination logistics.
Meet Our Reporters
-
Jill Drachenberg Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jill Drachenberg's Profile -
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
